Navigation Links
ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
Date:12/15/2011

YOKOHAMA, Japan, December 15, 2011 /PRNewswire/ --

ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company licensed worldwide right to commercialize hepatocytes derived from human iPS (induced pluripotent stem) cells. ReproCELL has been collaborating with the National Institute of Biomedical Innovation (NIBIO; Director General: Koichi Yamanishi; Osaka, Japan) to establish an effective in-vitro drug screening for hepatic toxicity and liver metabolism using hepatocytes derived from human iPS cells since early this year.

Together with NIBIO, the company successfully established the hepatocytes which highly express active drug metabolizing enzyme. Currently, the company is evaluating the system using various drugs with pharmaceutical companies to observe how the drugs are metabolized.  ReproCELL is anticipating its commercialization in Q2 2012. Prior to the launch, sample of the cells will become available for testing to pharmaceutical and biotech companies in January 2012.

ReproCELL is a world-leading pioneer in commercializing human pluripotent stem cells as an effective tool for drug discovery and development. The company has successfully launched iPS cell derived cardiomyocytes in April 2009 for cardiac toxicity testing, followed by the launch of iPS cell derived neuronal cells in October 2010 for efficacy screening of neuroactive compounds.

ReproCELL's Representative Director and CEO, Chikafumi Yokoyama PhD commented, "We are pleased to see iPS cell-derived hepatocytes showing the highest level of quality ever seen, expressing the same qualities as that of primary human hepatocytes currently used by the pharmaceutical industry, including drug metabolizing enzyme activity. We can expect to see its early adoption for drug toxicity and pharmacokinetic studies."

Aspects of NIBIO's technology on the induction of iPS cell-derived hepatocyte differentiation can be found in the following publication:


'/>"/>

SOURCE ReproCELL Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
2. SK Life Sciences has Licensed Pristima
3. NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
4. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
5. Full Agenda Announced for CMAC 2011 - CBIS 2nd Annual Commercialization and Market Access Congress
6. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
7. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
8. Saladax Biomedical, Inc. Announces European Commercialization Team
9. Reportlinker Adds Top & Emerging Bio-Fuel Markets by Technology, Feedstocks, Regulations, Pricing & Commercialization Trends & Forecasts (2011 - 2016)
10. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
11. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Nasseo, Inc. ... Innovation Challenge Winner out of hundreds of applicants by ... spring Arizona Innovation Challenge . The Arizona Innovation ... for a technology commercialization challenge, granting a financial award ... promising technology ventures. Nasseo’s state of the art dental ...
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... -- Third Wave Technologies Inc , a maker ... its Invader 2D6 analysis panel, which provides clinical trial ... assays available for the important 2D6 gene. , ,The ... trial laboratories the ability to configure custom assay panels. ...
... of competing together to race the fastest cars they can ... of 20 engineers, scientists and technicians from Ohio State University ... to win the $1 million dollar grand prize awarded to ... , ,The Defense Advanced Research Projects Agency (DARPA) has a ...
... DNASTAR, Inc . announced today the hiring and appointment ... of the Madison-based bioinformatics company. Schwei has 25 years ... with Promega Corporation, PanVera Corporation and Invitrogen Corporation. ... management and leadership, said Fred Blattner, DNASTARs chief of ...
Cached Biology Technology:Third Wave Releases Gene Test 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3
(Date:6/18/2013)... engineer has been awarded a $394,300 grant from ... quality and flow in the new facilities of ... UT Arlington associate professor of civil engineering, will ... monochloramine to the water in an effort to ... and pipelines. Adding monochloramine is widely practiced throughout ...
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... projected this century for Oregon,s Upper Willamette River ... transportation systems, human health, forests, and fish and ... University of Oregon,s Climate Leadership Initiative and the ... The authors say that extensive efforts should begin ...
... the DNA in the nucleus of each of our cells is ... molecules serve as coding templates for the synthesis of proteins. Of ... a scant few are known: they inhibit the activity of genes ... packaged within cells. What the rest of them do within cells ...
... University of Leeds are developing methods of helping contaminated ... such as vinegar. , The harmful chromium compounds ... former textiles factories, smelters, and tanneries have been linked ... with the kidneys, liver, lungs and skin. , The ...
Cached Biology News:Eugene-Springfield face Upper Willamette climate threats 2Eugene-Springfield face Upper Willamette climate threats 3Eugene-Springfield face Upper Willamette climate threats 4CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 2CSHL researchers pinpoint structure-building role for 2 non-coding RNAs 3Cleansing toxic waste -- with vinegar 2
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
... Early Drug Development with Imaging Mass Spectrometry ... compound localization data in early drug development ... spectrometry service maps unlabeled ions ... you can localize drugs and metabolites prior ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
... The ProteomeLab PF 2D is an ... of complex protein mixtures. Part of ... PF 2D produces results in just hours. ... of proteins present in cell lysates, addressing ...
Biology Products: